Hyprofractionated Versus Conventionally Fractionated Radiation Therapy for Patients with Intermediate- or High-Risk, Localized, Prostate Cancer: 7-Year Outcomes From the Randomized, Multicenter, Open-Label, Phase 3 HYPRO Trial.

Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):108-115.

Více informací ZDE 

Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial.

Radiother Oncol. 2020 Jan;142:52-61.

Více informací ZDE 

A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer.

Radiother Oncol. 2020 Jan;142:62-71.

Více informací ZDE 

Toxicity and Biochemical Outcomes of Dose-Intensified Postoperative Radiation Therapy for Prostate Cancer: Results of a Randomized Phase III Trial.

Int J Radiat Oncol Biol Phys. 2020 Feb 1;106(2):282-290.

Více informací ZDE 

Randomized clinical trial on reduction of radiotherapy dose to the elective neck in head and neck squamous cell carcinoma; update of the long-term tumor outcome.

Radiother Oncol. 2020 Feb;143:24-29.

Více informací ZDE 

Sequencing of Androgen-Deprivation Therapy With External-Beam Radiotherapy in Localized Prostate Cancer: A Phase III Randomized Controlled Trial.

J Clin Oncol. 2020 Feb 20;38(6):593-601.

Více informací ZDE 

Second Cancers in Patients With Locally Advanced Prostate Cancer Randomized to Lifelong Endocrine Treatment With or Without Radical Radiation Therapy: Long-Term Follow-up of the Scandinavian Prostate Cancer Group-7 Trial.

Int J Radiat Oncol Biol Phys. 2020 Mar 15;106(4):706-714.

Více informací ZDE 

Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial.

Int J Radiat Oncol Biol Phys. 2020 Mar 15;106(4):693-702.

Více informací ZDE 

Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III study.

Radiother Oncol. 2020 Mar;144:65-71.

Více informací ZDE 

Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel/cisplatin to standard radiotherapy with fluorouracil/cisplatin: The PacCis-trial.

Radiother Oncol. 2020 Mar;144:209-217.

Více informací ZDE 

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.

J Clin Oncol. 2020 Mar 1;38(7):706-714.

Více informací ZDE 

1